Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,449
Total Claims
$2.0M
Drug Cost
771
Beneficiaries
$2,532
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-15%
Opioid rate vs peers
1.9% vs 2.2% avg
+79%
Cost per patient vs peers
$2,532 vs $1,411 avg
+38%
Brand preference vs peers
14.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.9%
Opioid Rate
256
Opioid Claims
$4,401
Opioid Cost
4.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,958 claims · $1.7M
Generic: 11,374 claims · $275K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 204 | $317K |
| Dapagliflozin Propanediol | 202 | $222K |
| Apixaban | 202 | $201K |
| Empagliflozin | 114 | $155K |
| Fluticasone/Umeclidin/Vilanter | 67 | $85K |
| Rivaroxaban | 58 | $69K |
| Sitagliptin Phosphate | 44 | $58K |
| Vortioxetine Hydrobromide | 27 | $32K |
| Linaclotide | 41 | $31K |
| Dulaglutide | 14 | $30K |
| Budesonide/Formoterol Fumarate | 46 | $29K |
| Mirabegron | 49 | $27K |
| Linagliptin | 30 | $27K |
| Insulin Degludec | 22 | $26K |
| Canagliflozin | 12 | $24K |
Prescribing Profile
Patient Profile
76
Avg Age
51%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About